1. Home
  2. FUSE vs LSTA Comparison

FUSE vs LSTA Comparison

Compare FUSE & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fusemachines Inc.

FUSE

Fusemachines Inc.

HOLD

Current Price

$0.82

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$1.11

Market Cap

28.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FUSE
LSTA
Founded
2013
1980
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
28.9M
IPO Year
2025
2000

Fundamental Metrics

Financial Performance
Metric
FUSE
LSTA
Price
$0.82
$1.11
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
3.4M
113.8K
Earning Date
06-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
96.38
20.42
EPS
N/A
N/A
Revenue
$7,714,000.00
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.75
$0.99
52 Week High
$3.67
$5.07

Technical Indicators

Market Signals
Indicator
FUSE
LSTA
Relative Strength Index (RSI) 43.60 25.44
Support Level $0.81 $0.99
Resistance Level $1.93 $2.17
Average True Range (ATR) 0.17 0.10
MACD 0.00 0.06
Stochastic Oscillator 5.93 38.54

Price Performance

Historical Comparison
FUSE
LSTA

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: